{"id":212949,"url":"https://lda.senate.gov/api/v1/clients/212949/?format=json","client_id":12,"name":"DYNAVAX TECHNOLOGIES CORP.","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"CA","state_display":"California","country":"US","country_display":"United States of America","ppb_state":"CA","ppb_state_display":"California","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2021-11-15","registrant":{"id":401106326,"url":"https://lda.senate.gov/api/v1/registrants/401106326/?format=json","house_registrant_id":null,"name":"DYNAVAX TECHNOLOGIES CORP.","description":"Biopharmaceutical company focused on developing and commercializing novel vaccines.","address_1":"2100 Powell Street","address_2":"Suite 900","address_3":null,"address_4":null,"city":"Emeryville","state":"CA","state_display":"California","zip":"94608","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MARGARET MANN","contact_telephone":"+1 773-412-4368","dt_updated":"2026-01-29T11:49:13.095232-05:00"}}